What we know about mixing COVID-19 vaccine doses

(By Katie Adams for Becker’s Hospital Review)

The FDA is planning to allow Americans to receive a COVID-19 booster made by a different drugmaker than the one that made the vaccine with which they were initially inoculated, despite little peer-reviewed efficacy data on the practice.  Continue reading the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org